nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—Tamoxifen—pancreatic cancer	0.469	1	CbGbCtD
Fluoxymesterone—Peliosis hepatis—Tamoxifen—pancreatic cancer	0.0355	0.162	CcSEcCtD
Fluoxymesterone—Coma hepatic—Docetaxel—pancreatic cancer	0.0173	0.0789	CcSEcCtD
Fluoxymesterone—Oligospermia—Gemcitabine—pancreatic cancer	0.0146	0.0665	CcSEcCtD
Fluoxymesterone—Azoospermia—Gemcitabine—pancreatic cancer	0.0114	0.0518	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Tamoxifen—pancreatic cancer	0.00804	0.0366	CcSEcCtD
Fluoxymesterone—Hirsutism—Erlotinib—pancreatic cancer	0.00758	0.0345	CcSEcCtD
Fluoxymesterone—Oligospermia—Epirubicin—pancreatic cancer	0.00699	0.0318	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—pancreatic cancer	0.00646	0.0295	CcSEcCtD
Fluoxymesterone—Azoospermia—Epirubicin—pancreatic cancer	0.00544	0.0248	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Tamoxifen—pancreatic cancer	0.00506	0.0231	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—pancreatic cancer	0.00503	0.0229	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Docetaxel—pancreatic cancer	0.00392	0.0179	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Docetaxel—pancreatic cancer	0.00247	0.0113	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.00235	0.0107	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00229	0.0105	CcSEcCtD
Fluoxymesterone—Haemoglobin—Tamoxifen—pancreatic cancer	0.00225	0.0102	CcSEcCtD
Fluoxymesterone—Haemorrhage—Tamoxifen—pancreatic cancer	0.00223	0.0102	CcSEcCtD
Fluoxymesterone—Haemoglobin—Erlotinib—pancreatic cancer	0.00222	0.0101	CcSEcCtD
Fluoxymesterone—Haemorrhage—Erlotinib—pancreatic cancer	0.00221	0.0101	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—pancreatic cancer	0.00215	0.00979	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—pancreatic cancer	0.00199	0.00906	CcSEcCtD
Fluoxymesterone—Alopecia—Tamoxifen—pancreatic cancer	0.00197	0.009	CcSEcCtD
Fluoxymesterone—Alopecia—Erlotinib—pancreatic cancer	0.00195	0.00891	CcSEcCtD
Fluoxymesterone—Haemoglobin—Sunitinib—pancreatic cancer	0.00192	0.00877	CcSEcCtD
Fluoxymesterone—Haemorrhage—Sunitinib—pancreatic cancer	0.00191	0.00873	CcSEcCtD
Fluoxymesterone—Alopecia—Sunitinib—pancreatic cancer	0.00169	0.00771	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00167	0.00759	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—pancreatic cancer	0.00167	0.00759	CcSEcCtD
Fluoxymesterone—Anxiety—Tamoxifen—pancreatic cancer	0.00165	0.00752	CcSEcCtD
Fluoxymesterone—Anxiety—Erlotinib—pancreatic cancer	0.00163	0.00744	CcSEcCtD
Fluoxymesterone—Haemoglobin—Irinotecan—pancreatic cancer	0.00158	0.00722	CcSEcCtD
Fluoxymesterone—Haemorrhage—Irinotecan—pancreatic cancer	0.00158	0.00719	CcSEcCtD
Fluoxymesterone—Haemoglobin—Gemcitabine—pancreatic cancer	0.00154	0.00704	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—pancreatic cancer	0.00154	0.00703	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00154	0.00703	CcSEcCtD
Fluoxymesterone—Haemorrhage—Gemcitabine—pancreatic cancer	0.00154	0.007	CcSEcCtD
Fluoxymesterone—Haemoglobin—Fluorouracil—pancreatic cancer	0.00152	0.00692	CcSEcCtD
Fluoxymesterone—Haemorrhage—Fluorouracil—pancreatic cancer	0.00151	0.00688	CcSEcCtD
Fluoxymesterone—Paraesthesia—Tamoxifen—pancreatic cancer	0.00143	0.0065	CcSEcCtD
Fluoxymesterone—Alopecia—Irinotecan—pancreatic cancer	0.00139	0.00635	CcSEcCtD
Fluoxymesterone—Alopecia—Gemcitabine—pancreatic cancer	0.00136	0.00619	CcSEcCtD
Fluoxymesterone—Alopecia—Fluorouracil—pancreatic cancer	0.00133	0.00608	CcSEcCtD
Fluoxymesterone—Paraesthesia—Sunitinib—pancreatic cancer	0.00122	0.00557	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00117	0.00533	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00112	0.00511	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.0011	0.005	CcSEcCtD
Fluoxymesterone—Haemoglobin—Docetaxel—pancreatic cancer	0.0011	0.00499	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00109	0.00497	CcSEcCtD
Fluoxymesterone—Haemorrhage—Docetaxel—pancreatic cancer	0.00109	0.00497	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00107	0.00489	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00102	0.00463	CcSEcCtD
Fluoxymesterone—Paraesthesia—Irinotecan—pancreatic cancer	0.00101	0.00458	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Sunitinib—pancreatic cancer	0.001	0.00457	CcSEcCtD
Fluoxymesterone—Headache—Tamoxifen—pancreatic cancer	0.000995	0.00453	CcSEcCtD
Fluoxymesterone—Headache—Erlotinib—pancreatic cancer	0.000984	0.00449	CcSEcCtD
Fluoxymesterone—Paraesthesia—Gemcitabine—pancreatic cancer	0.00098	0.00447	CcSEcCtD
Fluoxymesterone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000963	0.00439	CcSEcCtD
Fluoxymesterone—Alopecia—Docetaxel—pancreatic cancer	0.000963	0.00439	CcSEcCtD
Fluoxymesterone—Nausea—Tamoxifen—pancreatic cancer	0.000943	0.0043	CcSEcCtD
Fluoxymesterone—Nausea—Erlotinib—pancreatic cancer	0.000933	0.00425	CcSEcCtD
Fluoxymesterone—Headache—Sunitinib—pancreatic cancer	0.000852	0.00388	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000825	0.00376	CcSEcCtD
Fluoxymesterone—Nausea—Sunitinib—pancreatic cancer	0.000808	0.00368	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00079	0.0036	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000774	0.00353	CcSEcCtD
Fluoxymesterone—Haemoglobin—Epirubicin—pancreatic cancer	0.000739	0.00337	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—pancreatic cancer	0.000735	0.00335	CcSEcCtD
Fluoxymesterone—Headache—Irinotecan—pancreatic cancer	0.000702	0.0032	CcSEcCtD
Fluoxymesterone—Paraesthesia—Docetaxel—pancreatic cancer	0.000695	0.00317	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000684	0.00312	CcSEcCtD
Fluoxymesterone—Headache—Gemcitabine—pancreatic cancer	0.000684	0.00312	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—pancreatic cancer	0.00068	0.0031	CcSEcCtD
Fluoxymesterone—Headache—Fluorouracil—pancreatic cancer	0.000672	0.00306	CcSEcCtD
Fluoxymesterone—Nausea—Irinotecan—pancreatic cancer	0.000665	0.00303	CcSEcCtD
Fluoxymesterone—Alopecia—Epirubicin—pancreatic cancer	0.00065	0.00296	CcSEcCtD
Fluoxymesterone—Nausea—Gemcitabine—pancreatic cancer	0.000648	0.00295	CcSEcCtD
Fluoxymesterone—Nausea—Fluorouracil—pancreatic cancer	0.000637	0.0029	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—pancreatic cancer	0.000601	0.00274	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Docetaxel—pancreatic cancer	0.00057	0.0026	CcSEcCtD
Fluoxymesterone—Anxiety—Epirubicin—pancreatic cancer	0.000543	0.00247	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000522	0.00238	CcSEcCtD
Fluoxymesterone—Anxiety—Doxorubicin—pancreatic cancer	0.000502	0.00229	CcSEcCtD
Fluoxymesterone—Headache—Docetaxel—pancreatic cancer	0.000485	0.00221	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000483	0.0022	CcSEcCtD
Fluoxymesterone—Paraesthesia—Epirubicin—pancreatic cancer	0.000469	0.00214	CcSEcCtD
Fluoxymesterone—Nausea—Docetaxel—pancreatic cancer	0.00046	0.0021	CcSEcCtD
Fluoxymesterone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000434	0.00198	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000385	0.00175	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000356	0.00162	CcSEcCtD
Fluoxymesterone—Headache—Epirubicin—pancreatic cancer	0.000327	0.00149	CcSEcCtD
Fluoxymesterone—Nausea—Epirubicin—pancreatic cancer	0.00031	0.00141	CcSEcCtD
Fluoxymesterone—Headache—Doxorubicin—pancreatic cancer	0.000303	0.00138	CcSEcCtD
Fluoxymesterone—Nausea—Doxorubicin—pancreatic cancer	0.000287	0.00131	CcSEcCtD
Fluoxymesterone—NR3C1—Gene Expression—CHD3—pancreatic cancer	0.000255	0.000816	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000255	0.000816	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000254	0.000814	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000253	0.000811	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000251	0.000806	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000249	0.000798	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000245	0.000786	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000245	0.000785	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000245	0.000785	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000245	0.000785	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000242	0.000777	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000241	0.000774	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CD—pancreatic cancer	0.00024	0.00077	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000236	0.000757	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000236	0.000757	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000235	0.000754	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GDI1—pancreatic cancer	0.000233	0.000745	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GDI2—pancreatic cancer	0.000233	0.000745	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—pancreatic cancer	0.00023	0.000736	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	0.000226	0.000725	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000225	0.000722	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000224	0.000719	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000224	0.000718	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TERT—pancreatic cancer	0.000224	0.000718	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CB—pancreatic cancer	0.000224	0.000716	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR5A2—pancreatic cancer	0.000217	0.000695	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HIF1A—pancreatic cancer	0.000214	0.000686	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TSC2—pancreatic cancer	0.000214	0.000684	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR5A2—pancreatic cancer	0.000213	0.000684	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000213	0.000684	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CB—pancreatic cancer	0.000209	0.000671	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—pancreatic cancer	0.000209	0.00067	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000208	0.000668	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000208	0.000668	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—pancreatic cancer	0.000208	0.000666	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000208	0.000666	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000208	0.000666	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	0.000207	0.000664	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000205	0.000658	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KDR—pancreatic cancer	0.000205	0.000656	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000204	0.000653	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000203	0.00065	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000201	0.000644	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	0.000199	0.000639	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—pancreatic cancer	0.000199	0.000636	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—pancreatic cancer	0.000198	0.000635	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000196	0.000629	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000196	0.000627	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFKBIA—pancreatic cancer	0.000195	0.000624	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000194	0.000622	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000194	0.000621	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—pancreatic cancer	0.000193	0.000619	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH1—pancreatic cancer	0.000193	0.000618	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000192	0.000615	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—pancreatic cancer	0.000189	0.000605	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000189	0.000604	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000187	0.000598	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGF—pancreatic cancer	0.000186	0.000598	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000186	0.000596	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—pancreatic cancer	0.000184	0.000588	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000182	0.000583	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000182	0.000582	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000181	0.000581	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—pancreatic cancer	0.000181	0.00058	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—pancreatic cancer	0.000181	0.000579	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000179	0.000574	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SRC—pancreatic cancer	0.000179	0.000574	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000178	0.000571	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000177	0.000567	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000173	0.000554	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—pancreatic cancer	0.000173	0.000554	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000173	0.000553	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—pancreatic cancer	0.000172	0.000552	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.00017	0.000545	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	0.000168	0.00054	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	0.000167	0.000537	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CD—pancreatic cancer	0.000166	0.000531	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000164	0.000527	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000163	0.000521	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000162	0.00052	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MEN1—pancreatic cancer	0.000162	0.000518	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—pancreatic cancer	0.000161	0.000518	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000161	0.000517	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.00016	0.000514	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000159	0.00051	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000158	0.000506	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—pancreatic cancer	0.000157	0.000503	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000157	0.000503	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—pancreatic cancer	0.000156	0.000501	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000156	0.000501	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000155	0.000496	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000155	0.000495	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH4—pancreatic cancer	0.000153	0.000491	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000152	0.000486	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000151	0.000485	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000151	0.000483	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.00015	0.000482	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.00015	0.000481	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRLHR—pancreatic cancer	0.00015	0.00048	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—pancreatic cancer	0.000148	0.000475	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000148	0.000474	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—pancreatic cancer	0.000147	0.000472	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPA1B—pancreatic cancer	0.000146	0.000468	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—pancreatic cancer	0.000145	0.000463	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000142	0.000454	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000141	0.000452	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000141	0.000452	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.00014	0.000448	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.00014	0.000448	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—pancreatic cancer	0.000139	0.000446	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—pancreatic cancer	0.000139	0.000445	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000138	0.000443	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—pancreatic cancer	0.000136	0.000437	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000136	0.000437	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000136	0.000436	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000135	0.000433	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000134	0.000428	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EZH2—pancreatic cancer	0.000133	0.000426	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—pancreatic cancer	0.000133	0.000426	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH3—pancreatic cancer	0.00013	0.000417	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—pancreatic cancer	0.000129	0.000415	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—pancreatic cancer	0.000128	0.000411	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—pancreatic cancer	0.000128	0.000409	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DTX1—pancreatic cancer	0.000127	0.000408	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SSTR3—pancreatic cancer	0.000127	0.000408	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—pancreatic cancer	0.000126	0.000404	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—pancreatic cancer	0.000126	0.000403	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000125	0.000402	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000125	0.000401	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—pancreatic cancer	0.000125	0.0004	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MEN1—pancreatic cancer	0.000124	0.000399	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000124	0.000398	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPA1A—pancreatic cancer	0.000123	0.000395	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MEN1—pancreatic cancer	0.000123	0.000393	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000123	0.000393	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SSTR1—pancreatic cancer	0.000122	0.000392	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPY—pancreatic cancer	0.00012	0.000384	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—pancreatic cancer	0.000118	0.000379	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH4—pancreatic cancer	0.000118	0.000378	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SSTR2—pancreatic cancer	0.000118	0.000377	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000117	0.000374	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	0.000116	0.000372	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—pancreatic cancer	0.000116	0.000371	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000116	0.000371	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000116	0.000371	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000114	0.000365	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCKBR—pancreatic cancer	0.000114	0.000364	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000113	0.000362	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—pancreatic cancer	0.000113	0.000362	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPA1B—pancreatic cancer	0.000113	0.000361	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—pancreatic cancer	0.000112	0.000358	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—pancreatic cancer	0.000111	0.000357	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—pancreatic cancer	0.000111	0.000357	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	0.000111	0.000355	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000109	0.00035	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000108	0.000345	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DTX4—pancreatic cancer	0.000107	0.000342	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLI1—pancreatic cancer	0.000107	0.000342	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000106	0.000341	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000105	0.000336	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—pancreatic cancer	0.000104	0.000334	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000104	0.000333	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRP1—pancreatic cancer	0.000104	0.000333	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—pancreatic cancer	0.000104	0.000333	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—pancreatic cancer	0.000104	0.000332	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000103	0.00033	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EZH2—pancreatic cancer	0.000102	0.000329	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—pancreatic cancer	0.000102	0.000325	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EZH2—pancreatic cancer	0.000101	0.000324	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH3—pancreatic cancer	0.0001	0.000322	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HEY2—pancreatic cancer	0.0001	0.00032	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	9.88e-05	0.000317	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMAD4—pancreatic cancer	9.81e-05	0.000314	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GAST—pancreatic cancer	9.77e-05	0.000313	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—pancreatic cancer	9.59e-05	0.000307	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPA1A—pancreatic cancer	9.5e-05	0.000305	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	9.36e-05	0.0003	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SCT—pancreatic cancer	9.26e-05	0.000297	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HEY1—pancreatic cancer	9.26e-05	0.000297	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCK—pancreatic cancer	8.83e-05	0.000283	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—pancreatic cancer	8.81e-05	0.000282	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.69e-05	0.000279	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLP1R—pancreatic cancer	8.61e-05	0.000276	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR2—pancreatic cancer	8.61e-05	0.000276	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—pancreatic cancer	8.52e-05	0.000273	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCKAR—pancreatic cancer	8.47e-05	0.000271	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAG2—pancreatic cancer	8.21e-05	0.000263	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—pancreatic cancer	8.15e-05	0.000261	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MEN1—pancreatic cancer	8.09e-05	0.000259	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	8.08e-05	0.000259	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SHH—pancreatic cancer	7.72e-05	0.000247	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH4—pancreatic cancer	7.67e-05	0.000246	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IAPP—pancreatic cancer	7.62e-05	0.000244	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMAD4—pancreatic cancer	7.56e-05	0.000242	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	7.44e-05	0.000239	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTHLH—pancreatic cancer	7.32e-05	0.000235	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTCH1—pancreatic cancer	7.32e-05	0.000235	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—pancreatic cancer	7.23e-05	0.000232	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—pancreatic cancer	7.2e-05	0.000231	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—pancreatic cancer	6.82e-05	0.000219	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SST—pancreatic cancer	6.69e-05	0.000215	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAG1—pancreatic cancer	6.55e-05	0.00021	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH3—pancreatic cancer	6.52e-05	0.000209	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—pancreatic cancer	6.22e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR1—pancreatic cancer	6.18e-05	0.000198	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	6.13e-05	0.000197	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GCG—pancreatic cancer	5.97e-05	0.000191	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGTR1—pancreatic cancer	5.69e-05	0.000182	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STK11—pancreatic cancer	5.61e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—pancreatic cancer	5.57e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	5.49e-05	0.000176	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—pancreatic cancer	5.26e-05	0.000168	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—pancreatic cancer	5.18e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMAD4—pancreatic cancer	4.91e-05	0.000157	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES1—pancreatic cancer	4.8e-05	0.000154	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—pancreatic cancer	4.2e-05	0.000135	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	4.02e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TSC2—pancreatic cancer	4.01e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—pancreatic cancer	3.92e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—pancreatic cancer	3.89e-05	0.000125	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—pancreatic cancer	3.84e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	3.66e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	3.62e-05	0.000116	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	3.54e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGF—pancreatic cancer	3.5e-05	0.000112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	3.11e-05	9.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—pancreatic cancer	3e-05	9.61e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—pancreatic cancer	2.95e-05	9.46e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	2.71e-05	8.7e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—pancreatic cancer	2.7e-05	8.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	2.61e-05	8.36e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—pancreatic cancer	2.5e-05	8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—pancreatic cancer	2.43e-05	7.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	2.41e-05	7.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—pancreatic cancer	2.36e-05	7.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—pancreatic cancer	2.34e-05	7.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—pancreatic cancer	2.17e-05	6.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	2.12e-05	6.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—pancreatic cancer	2.1e-05	6.72e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—pancreatic cancer	2.09e-05	6.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—pancreatic cancer	2.08e-05	6.66e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—pancreatic cancer	2.05e-05	6.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—pancreatic cancer	1.95e-05	6.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	1.94e-05	6.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—pancreatic cancer	1.91e-05	6.11e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—pancreatic cancer	1.8e-05	5.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.65e-05	5.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—pancreatic cancer	1.6e-05	5.13e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—pancreatic cancer	1.53e-05	4.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—pancreatic cancer	1.35e-05	4.33e-05	CbGpPWpGaD
